There is currently no antiviral treatment or licensed vaccine for dengue in India, which ranks among the top 30 countries with the highest incidence of the disease
Akeso, whose drug ivonescimab was hailed as biotech’s “DeepSeek moment” amid US competition last year, announced better-than-expected clinical results showing it can treat a type of lung cancer commonly found in smokers, potentially expanding its approved uses. Analysts suggest it could become a backbone therapy in the US$20 billion global non-small cell lung cancer market and have revised their target prices upwards. The drug’s phase three trial found that ivonescimab reduced the risk of death...
Chinese researchers claim to be outpacing international competitors in the development of stem cell therapies for Parkinson’s disease, citing higher efficiency and a faster clinical trial timeline. Parkinson’s is often described as a movement disorder. Its symptoms are caused by the brain’s failure to produce sufficient dopamine, because of the death or dysfunction of the specialised neurons responsible for generating the chemical. In the search for a cure, researchers around the world are...